How can you trust AI for healthcare if it’s never been tested in humans?
AI companies love to make bold claims about healthcare. Alphabet’s Isomorphic tells us that “frontier AI can unlock deeper scientific insights, faster breakthroughs, and life-changing medicines.” Lila confidently markets its AI as a tool for “faster discovery for every field where breakthrough science matters.” And they’re spending as though they believe the hype. Anthropic recently acquired stealth startup Coefficient Bio for $400 million.
How can you trust AI for healthcare if it’s never been tested in humans?
AI companies love to make bold claims about healthcare. Alphabet’s Isomorphic tells us that “frontier AI can unlock deeper scientific insights, faster breakthroughs, and life-changing medicines.” Lila confidently markets its AI as a tool for “faster discovery for every field where breakthrough science matters.” And they’re spending as though they believe the hype. Anthropic recently acquired stealth startup Coefficient Bio for $400 million. Fast Company Impact Council
